This site now provides key COVID-19-related ASPE research and analysis.
As of December 16, 2020, the list of Guidance and Information for Human Services program providers and stakeholders was archived and will no longer be updated.
New Publications
- Impact of COVID-19 on Clinical Trials Costs to Patients (July 2024)
- Transformation of the Clinical Trial Enterprise: Lessons Learned from the COVID-19 Pandemic (July 2024)
- Medicaid Home and Community-Based Services Section 1915(c) Waiver Policy Flexibilities During the COVID-19 Public Health Emergency: State Agency, Provider, and Consumer Experiences Issue Brief (June 2024)
- Tele-Behavioral Health Use Among Medicare Beneficiaries During COVID-19 (May 2024)
For any other information on COVID-19, including the latest CDC health guidance, refer to these sites:
- https://www.coronavirus.gov
- https://www.cdc.gov/coronavirus
- https://www.usa.gov/coronavirus (Spanish: https://www.usa.gov/espanol/coronavirus)
Last Updated: January 2, 2024